Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP).

Rashid MBMA, Toh TB, Hooi L, Silva A, Zhang Y, Tan PF, Teh AL, Karnani N, Jha S, Ho CM, Chng WJ, Ho D, Chow EK.

Sci Transl Med. 2018 Aug 8;10(453). pii: eaan0941. doi: 10.1126/scitranslmed.aan0941.

PMID:
30089632
2.

Datasets describing the growth and molecular features of hepatocellular carcinoma patient-derived xenograft cells grown in a three-dimensional macroporous hydrogel.

Fong ELS, Toh TB, Lin QXX, Liu Z, Hooi L, Rashid MBMA, Benoukraf T, Chow EK, Huynh TH, Yu H.

Data Brief. 2018 Mar 17;18:594-606. doi: 10.1016/j.dib.2018.03.045. eCollection 2018 Jun.

3.

Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy.

Zhao Y, Shuen TWH, Toh TB, Chan XY, Liu M, Tan SY, Fan Y, Yang H, Lyer SG, Bonney GK, Loh E, Chang KTE, Tan TC, Zhai W, Chan JKY, Chow EK, Chee CE, Lee GH, Dan YY, Chow PK, Toh HC, Lim SG, Chen Q.

Gut. 2018 Mar 30. pii: gutjnl-2017-315201. doi: 10.1136/gutjnl-2017-315201. [Epub ahead of print]

4.

Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer.

Fong ELS, Toh TB, Lin QXX, Liu Z, Hooi L, Mohd Abdul Rashid MB, Benoukraf T, Chow EK, Huynh TH, Yu H.

Biomaterials. 2018 Mar;159:229-240. doi: 10.1016/j.biomaterials.2017.12.026. Epub 2018 Jan 4.

PMID:
29353739
5.

Applications of stimuli-responsive nanoscale drug delivery systems in translational research.

Gu M, Wang X, Toh TB, Chow EK.

Drug Discov Today. 2018 May;23(5):1043-1052. doi: 10.1016/j.drudis.2017.11.009. Epub 2017 Nov 16. Review.

PMID:
29155366
6.

Stimuli-Responsive Nanodiamond-Based Biosensor for Enhanced Metastatic Tumor Site Detection.

Wang X, Gu M, Toh TB, Abdullah NLB, Chow EK.

SLAS Technol. 2018 Feb;23(1):44-56. doi: 10.1177/2472630317735497. Epub 2017 Oct 11.

PMID:
29020497
7.

3D Culture as a Clinically Relevant Model for Personalized Medicine.

Fong ELS, Toh TB, Yu H, Chow EK.

SLAS Technol. 2017 Jun;22(3):245-253. doi: 10.1177/2472630317697251. Epub 2017 Mar 9.

PMID:
28277923
8.

Epigenetics in cancer stem cells.

Toh TB, Lim JJ, Chow EK.

Mol Cancer. 2017 Feb 1;16(1):29. doi: 10.1186/s12943-017-0596-9. Review.

9.

Nanodiamond-Manganese dual mode MRI contrast agents for enhanced liver tumor detection.

Hou W, Toh TB, Abdullah LN, Yvonne TWZ, Lee KJ, Guenther I, Chow EK.

Nanomedicine. 2017 Apr;13(3):783-793. doi: 10.1016/j.nano.2016.12.013. Epub 2016 Dec 18.

PMID:
28003120
10.

TIP60 inhibits metastasis by ablating DNMT1-SNAIL2-driven epithelial-mesenchymal transition program.

Zhang Y, Subbaiah VK, Rajagopalan D, Tham CY, Abdullah LN, Toh TB, Gong M, Tan TZ, Jadhav SP, Pandey AK, Karnani N, Chow EK, Thiery JP, Jha S.

J Mol Cell Biol. 2016 Sep 20. pii: mjw038. [Epub ahead of print]

PMID:
27651430
11.

ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis.

Chong YK, Sandanaraj E, Koh LW, Thangaveloo M, Tan MS, Koh GR, Toh TB, Lim GG, Holbrook JD, Kon OL, Nadarajah M, Ng I, Ng WH, Tan NS, Lim KL, Tang C, Ang BT.

J Natl Cancer Inst. 2015 Nov 7;108(2). pii: djv326. doi: 10.1093/jnci/djv326. Print 2016 Feb.

12.

Identification and Optimization of Combinatorial Glucose Metabolism Inhibitors in Hepatocellular Carcinomas.

Mohd Abdul Rashid MB, Toh TB, Silva A, Nurrul Abdullah L, Ho CM, Ho D, Chow EK.

J Lab Autom. 2015 Aug;20(4):423-37. doi: 10.1177/2211068215579612. Epub 2015 Mar 30.

PMID:
25824204
13.

Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells.

Wang X, Low XC, Hou W, Abdullah LN, Toh TB, Mohd Abdul Rashid M, Ho D, Chow EK.

ACS Nano. 2014 Dec 23;8(12):12151-66. doi: 10.1021/nn503491e. Epub 2014 Dec 4.

14.

Nanodiamond-mitoxantrone complexes enhance drug retention in chemoresistant breast cancer cells.

Toh TB, Lee DK, Hou W, Abdullah LN, Nguyen J, Ho D, Chow EK.

Mol Pharm. 2014 Aug 4;11(8):2683-91. doi: 10.1021/mp5001108. Epub 2014 Jun 4.

15.

A distinct reactive oxygen species profile confers chemoresistance in glioma-propagating cells and associates with patient survival outcome.

Koh LW, Koh GR, Ng FS, Toh TB, Sandanaraj E, Chong YK, Phong M, Tucker-Kellogg G, Kon OL, Ng WH, Ng IH, Clement MV, Pervaiz S, Ang BT, Tang CS.

Antioxid Redox Signal. 2013 Dec 20;19(18):2261-79. doi: 10.1089/ars.2012.4999. Epub 2013 Apr 12.

PMID:
23477542
16.

Progenitor-like traits contribute to patient survival and prognosis in oligodendroglial tumors.

Ng FS, Toh TB, Ting EH, Koh GR, Sandanaraj E, Phong M, Wong SS, Leong SH, Kon OL, Tucker-Kellogg G, Ng WH, Ng I, Tang C, Ang BT.

Clin Cancer Res. 2012 Aug 1;18(15):4122-35. Epub 2012 Jun 6.

17.

Cryopreservation of cancer-initiating cells derived from glioblastoma.

Foong CS, Ng FS, Phong M, Toh TB, Chong YK, Tucker-Kellogg G, Campbell RM, Ang BT, Tang C.

Front Biosci (Schol Ed). 2011 Jan 1;3:698-708. Review.

PMID:
21196406
18.

Cryopreservation of neurospheres derived from human glioblastoma multiforme.

Chong YK, Toh TB, Zaiden N, Poonepalli A, Leong SH, Ong CE, Yu Y, Tan PB, See SJ, Ng WH, Ng I, Hande MP, Kon OL, Ang BT, Tang C.

Stem Cells. 2009 Jan;27(1):29-39. doi: 10.1634/stemcells.2008-0009.

19.

Antioxidants: promising neuroprotection against cardiotoxin-4b-induced cell death which triggers oxidative stress with early calpain activation.

Toh TB, Chen MJ, Armugam A, Peng ZF, Li QT, Jeyaseelan K, Cheung NS.

Toxicon. 2008 May;51(6):964-73. doi: 10.1016/j.toxicon.2007.11.019. Epub 2007 Nov 29.

PMID:
18377942

Supplemental Content

Support Center